Info

27. Martinez E, Sureda A, Dalmases CD, et al.: Mobilization of peripheral blood progenitor cells by cyclophos-phamide and rhGM-CSF in multiple myeloma. Bone Marrow Transplant 18(1):1-7, 1996.

28. Fitoussi O, Perreau V, Boiron JM, et al.: A comparison of toxicity following two different doses of cyclophos-phamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients. Bone Marrow Transplant 27(8):837-842, 2001.

29. Cremer FW, Kiel K, Wallmeier M, Haas R, Goldschmidt H, Moos M: Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone. Exp Hematol 26(10):969-975, 1998.

30. Alegre A, Tomas JF, Martinez-Chamorro C, et al.: Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone. Bone Marrow Transplant 20(3):211-217, 1997.

31. Oken MM, Harrington DP, Abramson N, Kyle RA, Knospe W, Glick JH: Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479. Cancer 79(8):1561-1567,

0 0

Post a comment